<DOC>
	<DOCNO>NCT01368055</DOCNO>
	<brief_summary>The purpose trial give short course ( 5 ½-6 week ) proton radiation little side effect normal bladder rectal tissue usual long course ( 8 week ) proton radiation , without decrease chance kill prostate cancer cell .</brief_summary>
	<brief_title>Hypofractionated Proton Radiation Therapy Low Intermediate Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate cancer . Gleason score 26 7 . PSA ≤ 20 ng/ml . Previous prostate cancer surgery pelvic radiation . Prior/concurrent systemic chemotherapy prostate cancer . Active inflammatory bowel disease ( Crohn 's disease , diverticulitis ulcerative colitis ) affect rectum . History hip replacement . Prior intrapelvic surgery . Taking Saw Palmetto methotrexate unable unwilling discontinue use radiation . Receiving continuous current anticoagulation Warfarin sodium ( Coumadin ) , Clopidogrel bisulfate ( Plavix ) , dabigatran etexilate mesylate ( Pradaxa ) , enoxaparin sodium ( Lovenox ) , aspirin/er dipyridamole ( Aggrenox ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Proton Radiation , Prostate Cancer</keyword>
</DOC>